Kotani H, Masuda N, Yamashita T, Naito Y, et al. Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study. Breast Cancer 2022 Jul 30. pii: 10.1007/s12282-022-01390.
PMID: 35907135